| Net Cash Provided by (Used in) Operating Activities |
$936,871 |
USD |
|
Q1 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Financing Activities |
$746,871 |
USD |
-6476% |
Q1 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Investing Activities |
$190,000 |
USD |
|
Q1 2025 |
Q1 2026 |
| Common Stock, Shares Authorized |
75,000,000 |
shares |
0% |
Q3 2025 |
Q3 2026 |
| Common Stock, Shares, Issued |
42,597,604 |
shares |
109% |
Q3 2025 |
Q3 2026 |
| Common Stock, Par or Stated Value Per Share |
0.001 |
USD/shares |
0% |
Q3 2025 |
Q3 2026 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$0 |
USD |
|
Q1 2025 |
Q1 2026 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$0 |
USD |
-100% |
Q3 2025 |
Q3 2026 |
| Deferred Tax Assets, Valuation Allowance |
$81,808 |
USD |
8.7% |
Q4 2024 |
FY 2025 |
| Depreciation |
$115 |
USD |
0% |
Q1 2024 |
Q1 2024 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$20,459 |
USD |
|
Q3 2025 |
Q3 2026 |
| Preferred Stock, Shares Issued |
1,000,300 |
shares |
|
Q3 2025 |
Q3 2026 |
| Preferred Stock, Shares Authorized |
10,000,000 |
shares |
|
Q3 2025 |
Q3 2026 |
| Additional Paid in Capital |
$6,901,877 |
USD |
-840% |
Q3 2025 |
Q3 2026 |
| Deferred Tax Assets, Net of Valuation Allowance |
$0 |
USD |
|
Q4 2024 |
FY 2025 |
| Interest Expense |
$98,826 |
USD |
|
Q3 2025 |
Q3 2026 |
| Preferred Stock, Par or Stated Value Per Share |
0.001 |
USD/shares |
|
Q3 2025 |
Q3 2026 |